Chronic traumatic encephalopathy risk in ice hockey increases with each year played

A study of 77 male hockey players reveals a 96.4% CTE prevalence, highlighting the link between play duration and increased risk of chronic encephalopathy.

HAEMATO AG (von GBC AG) – Biotech Investments

Original-Research: HAEMATO AG – von GBC AG Einstufung von GBC AG zu HAEMATO AG Unternehmen: HAEMATO AG ISIN: DE000A289VV1 Anlass der Studie: Research Note Empfehlung:

September 15, 2023

Atossa Therapeutics progresses Phase II preventative breast cancer therapy – Pharmaceutical Technology

Share this article Atossa Therapeutics’ CEO discussed updates for its breast cancer program. Credit: NDAB Creativity via Shutterstock Atossa Therapeutics estimates a Q3 readout of

January 26, 2024

Diet’s role in fighting vitiligo highlighted in new research

Diet and nutritional interventions rich in antioxidants show potential benefits in reducing the symptoms of vitiligo, emphasizing the need for further research to solidify dietary

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.